Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel antidiabetic agents in early development at Maxia

March 28, 2003

FDA approves Somavert for acromegaly

March 27, 2003

Orally active progesterone receptor modulator characterized at Meiji Seika

March 27, 2003

IntegraGen identifies therapeutic target in obesity

March 27, 2003

Merck describes new MCH receptor antagonists with utility in obesity

March 27, 2003

BVT-3498 enters phase II trial for type 2 diabetes

March 27, 2003

Amendment to miglustat NDA submitted

March 26, 2003

Basulin shows comparable pharmacokinetic profile to Lantus in healthy volunteers

March 26, 2003

Cathepsin K inhibitors and their use in osteoporosis reported by GSK

March 26, 2003

Chronic antagonism of the CB1 receptor results in antiobesity effects in mice

March 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...